Antimalarial Drug Resistance: A Threat to Malaria Elimination

被引:293
作者
Menard, Didier [1 ]
Dondorp, Arjen [2 ]
机构
[1] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh 12201, Cambodia
[2] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 73170, Thailand
基金
英国惠康基金;
关键词
PLASMODIUM-FALCIPARUM MALARIA; DIHYDROARTEMISININ-PIPERAQUINE FAILURE; IN-VITRO RESISTANCE; RICH PROTEIN-II; ARTEMISININ RESISTANCE; MULTIDRUG-RESISTANCE; WESTERN CAMBODIA; EX-VIVO; CHLOROQUINE RESISTANCE; MEFLOQUINE RESISTANCE;
D O I
10.1101/cshperspect.a025619
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Increasing antimalarial drug resistance once again threatens effective antimalarial drug treatment, malaria control, and elimination. Artemisinin combination therapies (ACTs) are first-line treatment for uncomplicated falciparum malaria in all endemic countries, yet partial resistance to artemisinins has emerged in the Greater Mekong Subregion. Concomitant emergence of partner drug resistance is now causing high ACT treatment failure rates in several areas. Genetic markers for artemisinin resistance and several of the partner drugs have been established, greatly facilitating surveillance. Single point mutations in the gene coding for the Kelch propeller domain of the K13 protein strongly correlate with artemisinin resistance. Novel regimens and strategies using existing antimalarial drugs will be needed until novel compounds can be deployed. Elimination of artemisinin resistance will imply elimination of all falciparum malaria from the same areas. In vivax malaria, chloroquine resistance is an increasing problem.
引用
收藏
页码:1 / 24
页数:24
相关论文
共 132 条
[1]   Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study [J].
Amaratunga, Chanaki ;
Lim, Pharath ;
Suon, Seila ;
Sreng, Sokunthea ;
Mao, Sivanna ;
Sopha, Chantha ;
Sam, Baramey ;
Dek, Dalin ;
Try, Vorleak ;
Amato, Roberto ;
Blessborn, Daniel ;
Song, Lijiang ;
Tullo, Gregory S. ;
Fay, Michael P. ;
Anderson, Jennifer M. ;
Tarning, Joel ;
Fairhurst, Rick M. .
LANCET INFECTIOUS DISEASES, 2016, 16 (03) :357-365
[2]  
Amaratunga C, 2014, LANCET INFECT DIS, V14, P449, DOI 10.1016/S1473-3099(14)70777-7
[3]   Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study [J].
Amaratunga, Chanaki ;
Sreng, Sokunthea ;
Suon, Seila ;
Phelps, Erika S. ;
Stepniewska, Kasia ;
Lim, Pharath ;
Zhou, Chongjun ;
Mao, Sivanna ;
Anderson, Jennifer M. ;
Lindegardh, Niklas ;
Jiang, Hongying ;
Song, Jianping ;
Su, Xin-zhuan ;
White, Nicholas J. ;
Dondorp, Arjen M. ;
Anderson, Tim J. C. ;
Fay, Michael P. ;
Mu, Jianbing ;
Duong, Socheat ;
Fairhurst, Rick M. .
LANCET INFECTIOUS DISEASES, 2012, 12 (11) :851-858
[4]  
[Anonymous], 2001, Antimalarial drug combination therapy. Report of a WHO Technical Consultation. WHO/CDS/RBM/2001.35
[5]  
[Anonymous], 2015, GUID TREATM MAL
[6]   A molecular marker of artemisinin-resistant Plasmodium falciparum malaria [J].
Ariey, Frederic ;
Witkowski, Benoit ;
Amaratunga, Chanaki ;
Beghain, Johann ;
Langlois, Anne-Claire ;
Khim, Nimol ;
Kim, Saorin ;
Duru, Valentine ;
Bouchier, Christiane ;
Ma, Laurence ;
Lim, Pharath ;
Leang, Rithea ;
Duong, Socheat ;
Sreng, Sokunthea ;
Suon, Seila ;
Chuor, Char Meng ;
Bout, Denis Mey ;
Menard, Sandie ;
Rogers, William O. ;
Genton, Blaise ;
Fandeur, Thierry ;
Miotto, Olivo ;
Ringwald, Pascal ;
Le Bras, Jacques ;
Berry, Antoine ;
Barale, Jean-Christophe ;
Fairhurst, Rick M. ;
Benoit-Vical, Franoise ;
Mercereau-Puijalon, Odile ;
Menard, Didier .
NATURE, 2014, 505 (7481) :50-+
[7]   Spread of Artemisinin Resistance in Plasmodium falciparum Malaria [J].
Ashley, E. A. ;
Dhorda, M. ;
Fairhurst, R. M. ;
Amaratunga, C. ;
Lim, P. ;
Suon, S. ;
Sreng, S. ;
Anderson, J. M. ;
Mao, S. ;
Sam, B. ;
Sopha, C. ;
Chuor, C. M. ;
Nguon, C. ;
Sovannaroth, S. ;
Pukrittayakamee, S. ;
Jittamala, P. ;
Chotivanich, K. ;
Chutasmit, K. ;
Suchatsoonthorn, C. ;
Runcharoen, R. ;
Hien, T. T. ;
Thuy-Nhien, N. T. ;
Thanh, N. V. ;
Phu, N. H. ;
Htut, Y. ;
Han, K-T. ;
Aye, K. H. ;
Mokuolu, O. A. ;
Olaosebikan, R. R. ;
Folaranmi, O. O. ;
Mayxay, M. ;
Khanthavong, M. ;
Hongvanthong, B. ;
Newton, P. N. ;
Onyamboko, M. A. ;
Fanello, C. I. ;
Tshefu, A. K. ;
Mishra, N. ;
Valecha, N. ;
Phyo, A. P. ;
Nosten, F. ;
Yi, P. ;
Tripura, R. ;
Borrmann, S. ;
Bashraheil, M. ;
Peshu, J. ;
Faiz, M. A. ;
Ghose, A. ;
Hossain, M. A. ;
Samad, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (05) :411-423
[8]   Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates [J].
Bacon, David J. ;
Latour, Christine ;
Lucas, Carmen ;
Colina, Olga ;
Ringwald, Pascal ;
Picot, Stephane .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1172-1178
[9]   A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes [J].
Barnadas, Celine ;
Kent, David ;
Timinao, Lincoln ;
Iga, Jonah ;
Gray, Laurie R. ;
Siba, Peter ;
Mueller, Ivo ;
Thomas, Peter J. ;
Zimmerman, Peter A. .
MALARIA JOURNAL, 2011, 10
[10]   Increased gametocytemia after treatment: An early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria [J].
Barnes, Karen I. ;
Little, Francesca ;
Mabuza, Aaron ;
Mngomezulu, Nicros ;
Govere, John ;
Durrheim, David ;
Roper, Cally ;
Watkins, Bill ;
White, Nicholas J. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (11) :1605-1613